Figure 1. Codon‐dependent translation regulation of HIF1α couples glycolytic metabolism to drug resistance in melanoma.
Cartoon depicts the proposed mechanism by which increased activation of U34 tRNA‐modifying enzymes promotes HIF1α protein synthesis, leading to enhanced glycolysis and conferring mTORC2‐dependent resistance toward targeted BRAF inhibition.